Results 131 to 140 of about 49,735 (302)

Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis

BMC Pediatrics
Intravenous immunoglobulin (IVIg) is a first-line treatment for children with newly diagnosed immune thrombocytopenia (ITP). Higher doses of IVIg are associated with a more insupportable financial burden to pediatric patients’ families and may produce ...
Xiangge Ren, Miaomiao Zhang, Xiaohan Zhang, Peidong Zhao, Wensheng Zhai   +4 more
doaj   +1 more source

Preparation of different glycoforms of intravenous immunoglobulin (IVIG).

, 2014
Deglycosylated, agalactosylated, galactosylated and sialylated forms were prepared from conventional IVIG by treatment with PNGase F, sialidase and galactosidase, galactosyltransferase, and galactosyltransferase and sialyltransferase, respectively.
Nobuhiro Yuki (60770), Nortina Shahrizaila (635406), Makoto Sudo (635402), Peter J. Späth (635403), Benjamin K. Ong (635405), Yoshiki Yamaguchi (132437), Kana Matsumoto-Morita (635404)   +6 more
core   +1 more source

Seizure improvement following intravenous immunoglobulin in drug‐resistant mesial temporal lobe epilepsy associated with systemic lupus erythematosus

Epileptic Disorders, EarlyView.
Kristijonas Puteikis, Basma Marzouk, Fabrice Bartolomei, Stanislas Lagarde   +3 more
wiley   +1 more source

A Retrospective Study on Neonatal Jaundice: Early Risk Stratification Value of DAT‐FAT Serological Profiles Confirmed by AET

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This retrospective study aimed to explore the value of DAT‐FAT serological profiles confirmed by AET in classifying neonatal jaundice, evaluating its severity, and guiding clinical management. A total of 915 jaundiced newborns (584 pathological, 331 physiological) admitted from July 2018 to August 2021 were included.
Tian‐Ge Wu, Yan‐Feng Zhang, Zhong‐Jun Shen, Yao Li, Ning Xu, Xiao‐Yi Liu, Li‐Yan Zhao, Ming‐Hao Shi   +7 more
wiley   +1 more source

Laboratory data before IVIG treatment in the Kawasaki disease patients.

, 2015
IVIG: intravenous immunoglobulin; CRP: C reactive peptideLaboratory data before IVIG treatment in the Kawasaki disease patients.
Ying-Hsien Huang (446595), Mao-Hung Lo (534115), Mindy Ming-Huey Guo (615611), Kai-Sheng Hsieh (437111), Ho-Chang Kuo (156547)   +4 more
core   +1 more source

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study

Pediatric Rheumatology Online Journal
Background Infliximab (IFX) is a reliable choice of treatment for intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) patients. Nationwide surveys in Japan demonstrated that additional treatment was still required for 20–30% of patients ...
Satoki Hatano, Hiro Nakao, Hiroshi Masuda, Hiroshi Ono, Mitsuru Kubota, Akira Ishiguro   +5 more
doaj   +1 more source

Exteroceptive Reflexes in Stiff Person Syndrome, Other Neurological Conditions and Healthy Controls

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Stiff person syndrome (SPS) is a rare disabling neurological condition with overlapping symptomatology with more common neurological conditions. Exaggerated exteroceptive reflex mechanisms are thought to play a role in its pathophysiology.
Belinda Cruse, Duncan Wilson, Hugo Morales Briceno, Pamela Garcia, Victor Zhang, Jessica Qiu, Tomas Kalincik, Neil Mahant, Victor Shue Chung Fung   +8 more
wiley   +1 more source

Invigorating IVIG [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Early Remission of Cerebrospinal Fluid Interleukin‐6 After Initial Immunotherapy Predicts a Good Prognosis in Autoimmune Encephalitis

Neurology and Clinical Neuroscience, EarlyView.
ABSTRACT Background Autoimmune encephalitis therapy requires adjusting the regimen based on therapeutic response; however, clinical indicators of this response remain unknown. Aim To determine the predictive capability of cerebrospinal fluid (CSF), electroencephalography (EEG), and brain magnetic resonance imaging (MRI) in identifying responders to ...
Yuta Madokoro, Yuto Uchida, Hiroyasu Inoue, Toyohiro Sato, Teppei Fujioka, Masayuki Mizuno, Shoji Kawashima, Masahiro Oomura, Noriyuki Matsukawa   +8 more
wiley   +1 more source

Management of Refractory Thymoma‐Associated Myasthenia Gravis With Sequential FcRn Antagonist and Complement Inhibition Combined With Resection of Pleural Dissemination

Neurology and Clinical Neuroscience, EarlyView.
ABSTRACT Myasthenia gravis (MG) associated with disseminated thymoma is often refractory to conventional treatments due to continuous autoantibody production. The optimal treatment strategy, particularly the combination of complement component 5 (C5) inhibitor, neonatal Fc receptor (FcRn) antagonist, and surgical resection in thymoma‐associated ...
Hiroyuki Takenaka, Madoka Iida, Yuki Fukami, Masahisa Katsuno   +3 more
wiley   +1 more source